证据
- In people with multiple myeloma, how does bortezomib affect outcomes?
- Can adding plerixafor to granulocyte colony‐stimulating factor (G‐CSF) improve outcomes in people undergoing autologous transplantation for multiple myeloma or non‐Hodgkin lymphoma?
- How do bisphosphonates compare with placebo/no treatment and each other in people with multiple myeloma?
使用此内容应接受我们的免责声明。
